leflunomide has been researched along with Meigs Syndrome in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Meigs Syndrome: The triad of benign FIBROMA or other ovarian tumors with ASCITES, and HYDROTHORAX due to large PLEURAL EFFUSIONS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Herein, we present a case of a 47-year-old female patient who developed Tjalma syndrome after administration of leflunomide for rheumatoid arthritis." | 7.77 | Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy. ( Bes, C; Soy, M, 2011) |
| " Herein, we present a case of a 47-year-old female patient who developed Tjalma syndrome after administration of leflunomide for rheumatoid arthritis." | 3.77 | Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy. ( Bes, C; Soy, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bes, C | 1 |
| Soy, M | 1 |
1 other study available for leflunomide and Meigs Syndrome
| Article | Year |
|---|---|
Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; CA-125 Antigen; Diagnosis, Differential; Female; Humans | 2011 |